PharmaBoardroom

Decision Time for APAC Pharma: Step Up or Sit Back?

Ai Hua Ong, Asia-Pacific company group chairman of Janssen, the Pharmaceutical Companies of Johnson & Johnson, looks back at the tremendous…

The Fight Against Superbugs Heats Up

Boston University School of Law’s Kevin Outterson* looks at how cost-saving measures are contributing to the rise of drug-resistant “superbugs”…

The Role of Patient Associations in Rare Disease Drug Development

Monica Weldon, CEO and president of Bridge the Gap – SYNGAP Education and Research Foundation, shares her recent experience at the US Drug Law and…

A Pharma Funding Overview & Outlook for 2020

Michael Jewell, partner and head of healthcare & life sciences at Cavendish Corporate Finance looks back at the key trends across pharma industry…

Antibiotics: Responsibly Making the Drugs Society Needs

Steve Brooks, Advisor to the AMR Industry Alliance, outlines the threat that antimicrobial resistance (AMR) poses to global health, how antibiotic…

The Role of Cross-Sector Collaborations in Advancing Access to…

The IFPMA’s Greg Perry shares some of the key findings from a panel discussion on access to healthcare products at the 2019 World Health Summit in…

Three Key Political Issues for Pharma: Protests, Pricing &…

This month, Aditya Bhattacharji takes stock of three political issues that are dominating Eurasia Group’s conversations with pharmaceutical firms:…

Private Equity Targeting Healthcare & Consulting Comms…

Anthony Harrington of global investment banking and asset management firm Alantra outlines why healthcare and consulting communications companies are…

US FDA’s Efforts to Advance the Development of Gene Therapy

Peter Marks, director of the US FDA's Center for Biologics Evaluation and Research, outlines how the organization is attempting to further promote the…

Biosimilars Work. Why Aren’t They Taking Off in the US?

The AAM’s Chip Davis examines the roadblocks to greater adoption of biosimilar drugs in the USA, and why they need to be removed to potentially save…

Three Basic Truths About the US Healthcare System

AstraZeneca's Rick R. Suarez looks at workable solutions to the challenges facing healthcare in the US and why inter-stakeholder collaboration, rather…

Cybersecurity: A Health Business Risk Requiring Executive…

Carla Smith looks at the various cybersecurity risks that exist across the US healthcare continuum and the steps that executive leadership can take to…

Tagged with Opinion